Coupling a C12-alkyl chain to a lactoferricin-derived peptide dramatically enhanced LPS (endotoxin) neutralization, potentially preventing sepsis-driving inflammatory cascades at the source.
Key findingC12-alkyl chain coupling to a lactoferricin-derived peptide enhanced LPS neutralization by over 10-fold while maintaining antimicrobial activity, crea
What the researchers found
C12-alkyl chain coupling to a lactoferricin-derived peptide enhanced LPS neutralization by over 10-fold while maintaining antimicrobial activity, creating a dual-function peptide that both kills bacteria and neutralizes their toxic products.
Why it matters
Relevant for antimicrobial-peptides, infection, peptide-design.
How the study worked
in-vitro study on antimicrobial-peptides, infection.
What this study cannot tell us
See abstract.
How to read the evidence
preliminary evidence.
When this study was published
Published in 2005.
The bigger picture
Advances peptide/biomarker research with clinical implications.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide.
The Biochemical journal, 385(Pt 1), 135-43
Citation
Andrä, Jörg; Lohner, Karl; Blondelle, Sylvie E; Jerala, Roman; Moriyon, Ignacio; Koch, Michel H J; Garidel, Patrick; Brandenburg, Klaus. (2005). Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide.. The Biochemical journal, 385(Pt 1), 135-43.